Unicycive Therapeutics, Inc. Common Stock (UNCY) Stock Price, Quote & AI Analysis
Live UNCY stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Unicycive Therapeutics, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Unicycive Therapeutics, Inc. Common Stock (UNCY), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Unicycive Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Unicycive Therapeutics, Inc. Common Stock Overview
Company information
Company Overview
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Unicycive Therapeutics, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...